Physician profile
Brian Conway
NPI 1699209106
$17,047.28
in general payments reported to CMS, 2019-2025
37 companies · $3,598 in 2025
The $3,598 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $542 · 2022: $995 · 2023: $9,947 · 2024: $1,966 · 2025: $3,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,000 · Food and Beverage: $4,413 · Travel and Lodging: $2,932 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,000.00 |
| Food and Beverage | $4,412.83 |
| Travel and Lodging | $2,932.47 |
| Education | $165.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,349.08 | 2021-2025 | Onyx Frontier |
| Abbott Laboratories | $2,222.52 | 2021-2025 | Amplatzer Amulet, Triclip, Diamondback Coronary |
| Edwards Lifesciences Corporation | $1,871.15 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abiomed | $891.97 | 2022-2025 | Impella |
| Boston Scientific Corporation | $603.29 | 2021-2025 | Farapulse |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $385.25 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.34 | 2021-2025 | Jardiance |
| Irhythm Technologies, INC. | $312.57 | 2022 | |
| Shockwave Medical, INC | $303.71 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $269.42 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $175.85 | 2024-2025 | Verquvo, Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $152.29 | 2024-2025 | |
| Cordis US Corp. | $102.06 | 2023 | Mynx Control |
| Actelion Pharmaceuticals US, INC. | $99.91 | 2025 | Uptravi |
| Heartflow, INC. | $88.44 | 2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Lantheus Medical Imaging, INC. | $75.60 | 2021 | |
| Terumo Medical Corporation | $74.75 | 2023 | Glidesheath Slender, Glidewire, Navicross |
| Penumbra, INC. | $63.06 | 2023 | Indigo System |
| Inspire Medical Systems, INC. | $54.84 | 2025 | Inspire |
| Bridgebio Pharma, INC. | $52.78 | 2025 | Attruby |
| Gilead Sciences, INC. | $44.62 | 2024 | |
| Novartis Pharmaceuticals Corporation | $43.37 | 2025 | |
| Biosense Webster, INC. | $38.68 | 2025 | Nuvision Ice Catheter |
| Pfizer INC. | $37.96 | 2021-2025 | |
| Teleflex LLC | $33.72 | 2023 | Guideliner |
| Amgen INC. | $30.96 | 2024-2025 | Repatha, Repatha |
| Novo Nordisk INC | $30.22 | 2025 | Wegovy |
| Sensible Medical Innovations INC | $27.65 | 2025 | Reds System |
| Baxter Healthcare | $26.86 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $25.97 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $24.90 | 2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $22.98 | 2023 | Xarelto |
| Philips North America LLC | $22.88 | 2022 | |
| Glaxosmithkline, LLC. | $22.08 | 2025 | Arexvy |
| Acist Medical Systems, INC. | $18.46 | 2024 | |
| Vital Connect, INC | $15.97 | 2025 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Conway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.